← All Investors
BIO RAD LABS INC
BIO
Holders
10
Combined Value
$418M
Combined Shares
1,502,339
Current Price
$284.67
52W High
$343.12
vs 52W High
−17.0%
Investor Activity
BUYSELLImplied priceClick a quarter to see who traded
Held By
| Investor | Value | % of Portfolio | Avg Buy Price | Gain | Last Activity | As of |
|---|---|---|---|---|---|---|
| John Rogers - Ariel Investments | $219M | 2.45% | ~$295.97 | −3.8% | Bought Q1 2026 | Q1 2026 |
| Mason Hawkins - Southeastern Asset Management | $45M | 2.23% | ~$271.71 | +4.8% | Sold Q1 2026 | Q1 2026 |
| Joel Greenblatt - Gotham Asset Management | $42M | 0.13% | ~$264.55 | +7.6% | Bought Q1 2026 | Q1 2026 |
| Ken Griffin - Citadel Advisors | $41M | 0.01% | ~$278.59 | +2.2% | Bought Q1 2026 | Q1 2026 |
| Ken Fisher - Fisher Investments | $33M | 0.01% | ~$271.00 | +5.0% | Sold Q1 2026 | Q1 2026 |
| Cliff Asness - AQR Capital | $26M | 0.01% | ~$273.70 | +4.0% | Bought Q1 2026 | Q1 2026 |
| Mario Gabelli - GAMCO Investors | $7M | 0.07% | ~$273.11 | +4.2% | Bought Q2 2024 | Q1 2026 |
| Paul Tudor Jones - Tudor Investment | $1M | 0.00% | ~$278.75 | +2.1% | Bought Q1 2026 | Q1 2026 |
| Israel Englander - Millennium Management | $1M | 0.00% | ~$322.99 | −11.9% | Sold Q1 2026 | Q1 2026 |
| Ray Dalio - Bridgewater Associates | $469K | 0.00% | ~$278.75 | +2.1% | Bought Q1 2026 | Q1 2026 |
Recent Activity
Ownership History
| Period | Holders | Total Shares | Δ Shares | Total Value | Implied Price |
|---|---|---|---|---|---|
| Q1 2026 | 10 | 1,502,339 | +10.8% | $418M | $278.53 |
| Q4 2025 | 8 | 1,356,145 | −7.3% | $410M | $302.99 |
| Q3 2025 | 10 | 1,463,134 | −13.6% | $410M | $280.23 |
| Q2 2025 | 8 | 1,693,419 | +1.8% | $408M | $241.32 |
| Q1 2025 | 9 | 1,664,153 | −4.7% | $405M | $243.50 |
| Q4 2024 | 11 | 1,746,311 | −3.9% | $573M | $328.51 |
| Q3 2024 | 10 | 1,816,688 | +142.5% | $607M | $334.52 |
| Q2 2024 | 9 | 749,012 | — | $204M | $273.10 |